Home
Search
Placeholder Banner
Letters, Testimony and Comments

BIO Response to RFI: National Biotechnology & Biomanufacturing Initiative

January 23, 2023

BIO's response to the Office of Science & Technology Policy's Request for Information concerning the National Biotechnology & Biomanufacturing Initiative

Download Full Comments Below
BIO Response to RFI: National Biotechnology & Manufacturing Initiative

BIO's response to the Office of Science & Technology Policy's Request for Information concerning the National Biotechnology and Biomanufacturing Initiative

Download
Discover More
BIO comments to USTR on the Agency’s 2023 Special…
Learn more
BIO Submits Comments on FDA Guidance: Measuring…
On Tuesday, January 3rd, BIO submitted comments in response to the Food and Drug Administration’s (FDA) recent draft guidance containing recommendations for sponsors on monitoring growth and evaluating pubertal development in clinical trials which…
Learn more
BIO Comments on Patient-Focused Drug Development:…
BIO and its members appreciate the opportunity to work with FDA to develop and align on approaches that are robust, practical, and expedite patient focused drug development. To further enhance the Guidance, we believe that a few areas would benefit…
Learn more